Cargando…
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
Recently, liquid biopsy has emerged as a tool to monitor oncologic disease progression and the effects of treatment. In this study we aimed to determine the clinical utility of liquid biopsy relative to conventional oncological post-treatment surveillance. Plasma cell-free (cf) DNA was collected fro...
Autores principales: | Niwinska, Anna, Bałabas, Aneta, Kulecka, Maria, Kluska, Anna, Piątkowska, Magdalena, Paziewska, Agnieszka, Pyśniak, Kazimiera, Olszewski, Wojciech, Mikula, Michał, Ostrowski, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460238/ https://www.ncbi.nlm.nih.gov/pubmed/32731384 http://dx.doi.org/10.3390/diagnostics10080523 |
Ejemplares similares
-
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015) -
Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020) -
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
por: Lugowska, Iwona, et al.
Publicado: (2018) -
Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019) -
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
por: Kluska, Anna, et al.
Publicado: (2017)